Krilogy Financial’s Kura Oncology KURA Stock Holding History

Krilogy Financial’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,715	Closed	-$100K	–	1022
2025 Q4	$100K	Sell	11,715 -2,472	-17%	-$25.9K	﹤0.01%	902
2025 Q3	$141K	Buy	+14,187	New	+$101K	0.01%	837

Other funds holding KURA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Krilogy Financial's KURA Position: Q1 2026 in Review

Krilogy Financial sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 11,715 shares — an estimated $100K sold.

Krilogy Financial first reported a position in KURA in Q3 2025 and held it in 2 quarters. The position peaked at $141K in Q3 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

Krilogy Financial reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
Krilogy Financial sold 11,715 Kura Oncology shares in Q1 2026, an estimated $100K.
Krilogy Financial first reported a position in Kura Oncology in Q3 2025 and held it in 2 quarters.
Krilogy Financial's Kura Oncology position peaked at $141K in Q3 2025.
220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Krilogy Financial's 13F filing for Q1 2026, filed 17 Apr 2026.